Pre-made Valanafusp benchmark antibody ( Whole mAb Fusion, anti-INSR therapeutic antibody, Anti-CD220/HHF5 Antibody) for drug discovery and mechanism of action (MOA) research
Cat No.: GMP-Bios-ab-608
Pre-Made Valanafusp biosimilar, Whole mAb Fusion, Anti-INSR Antibody: Anti-CD220/HHF5 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Valanafusp alpha is a BBB-penetrating form of IDUA, and is designed to deliver the IDUA enzyme to brain cells to reverse the accumulation of heparan sulfate (HS) GAGs and lysosomal inclusions. The primary therapeutic goal of valanafusp alpha therapy is stabilization of cognitive decline in severe MPSI.
Order information
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Catalog No. | Package | Price(In USD) | Qty (Quantity) | Sum(In USD) |
---|---|---|---|---|
GMP-Bios-ab-608-1mg | 1mg | Inquiry | ||
GMP-Bios-ab-608-10mg | 10mg | Inquiry | ||
GMP-Bios-ab-608-100mg | 100mg | Inquiry | ||
GMP-Bios-ab-608-xmg | >100mg | Inquiry | ||
Shipping Cost: | 760.00 | |||
Total: | ||||
Description
Products Name (INN Index) | Pre-Made Valanafusp biosimilar, Whole mAb Fusion, Anti-INSR Antibody: Anti-CD220/HHF5 therapeutic antibody |
INN Name | Valanafusp |
Target | INSR |
Format | Whole mAb Fusion |
Derivation | |
Species Reactivity | Human |
CH1 Isotype | IgG1 |
VD LC | Kappa |
Highest_Clin_Trial (Jan '20) | Phase-II |
Est. Status | Active |
100% SI Structure | None |
99% SI Structure | 5kqv:PQ:CD/4zxb:CD |
95-98% SI Structure | 3loh:CD/2dtg:CD/3w14:CD:PQ |
Year Proposed | 2017 |
Year Recommended | 2018 |
Companies | ArmaGen Technologies |
Conditions Approved | na |
Conditions Active | Mucopolysaccharidosis I |
Conditions Discontinued | na |
Development Tech | na |
- GENEMEDI
- Email: [email protected] [email protected]
- Telephone: +86-21-50478399 Fax: 86-21-50478399
- Privacy Policy
- TECHNICAL SUPPORT
- Product FAQs
- Technical manuals
- Publications
- Email: [email protected]
<